ClinicalTrials.Veeva
Menu

Find clinical trials for Lymphoma in Tampa, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Lymphoma
Non-Hodgkin Lymphoma
Diffuse Large B-Cell Lymphoma
Leukemia
Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Cell Chronic Lymphocytic Leukemia
Lymphoid Leukemia

Lymphoma trials near Tampa, FL, USA:

A Pilot Study of Acalabrutinib in Relapsed/Refractory Primary and Secondary CNS Lymphomas

The purpose of this study is to test whether giving acalabrutinib is safe and effective in controlling relapsed central nervous system (CNS) lymphoma...

Active, not recruiting
Central Nervous System Lymphoma
Drug: Acalabrutinib

Phase 2

UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center

Tampa, Florida, United States and 2 other locations

The purpose of the study is to establish the safety and efficacy of zanubrutinib in combination with rituximab for people with untreated B-cell lymphomas...

Enrolling
Marginal Zone Lymphoma
B-Cell Lymphoma
Drug: Zanubrutinib
Drug: Rituximab

Phase 2

H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute

Tampa, Florida, United States

The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of CC-99282 alone and in combination with anti-lymphoma...

Active, not recruiting
Lymphoma, Non-Hodgkin
Drug: Obinutuzumab
Drug: CC-99282

Phase 1, Phase 2

Celgene
Celgene

Tampa, Florida, United States and 68 other locations

of ALLO-501 in adults with relapsed or refractory large B-cell lymphoma or follicular lymphoma after a lymphodepletion regimen comp...

Active, not recruiting
Relapsed/Refractory Follicular Lymphoma
Relapsed/Refractory Large B Cell Lymphoma
Genetic: ALLO-501
Drug: Fludarabine

Phase 1

Allogene Therapeutics

Tampa, Florida, United States and 6 other locations

to assess the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma...

Enrolling
Lymphoma, Follicular
Drug: Golcadomide
Drug: Doxorubicin

Phase 2

Celgene
Celgene

Tampa, Florida, United States and 67 other locations

by the intravenous (IV) route to participants with solid tumors or lymphomas.The main goals of this study are to:* Find the recommended dose...

Active, not recruiting
Hodgkin Lymphoma
Follicular Lymphoma
Combination Product: Fruquintinib
Drug: IMT-009

Phase 1, Phase 2

Immunitas Therapeutics

Sarasota, Florida, United States and 8 other locations

of this study is to characterize the safety and efficacy profile of ACP-196 (acalabrutinib) in subjects with relapsed or refractory Mantle Cell Lymphoma...

Active, not recruiting
Mantle Cell Lymphoma (MCL)
Drug: ACP-196 (acalabrutinib)

Phase 2

Acerta Pharma
Acerta Pharma

Tampa, Florida, United States and 57 other locations

choice in participants with relapsed/refractory follicular lymphoma who have received at least one line of prior systemic therapy....

Enrolling
Follicular Lymphoma
Drug: Golcadomide
Drug: Rituximab

Phase 3

Celgene
Celgene

Tampa, Florida, United States and 159 other locations

The purpose of this trial is to measure the following in participants with relapsed and/or refractory B-cell lymphoma who receive epcoritama...

Active, not recruiting
Aggressive B-cell Non-Hodgkin Lymphoma (aNHL)
Small Lymphocytic Lymphoma (SLL)
Biological: Epcoritamab

Phase 1, Phase 2

Genmab
Genmab

Tampa, Florida, United States and 84 other locations

This is an open-label, multi-center Phase 1b clinical study of oral AS-1763 (docirbrutinib) in patients with CLL/SLL or B-cell NHL who have failed or...

Enrolling
Marginal Zone Lymphoma
Follicular Lymphoma
Drug: Docirbrutinib

Phase 1

Carna Biosciences

Tampa, Florida, United States and 11 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems